• Home
  • Biopharmaceutical Research Services
  • Multi-Omics Services
  • Support
  • /assets/images/icon/icon-email-2.png

    Email:

    info@MtoZ-Biolabs.com

    Amino Acid Mass Spectrometry

      Amino acid mass spectrometry refers to analytical methods utilizing mass spectrometry to achieve highly sensitive and specific qualitative and quantitative analysis of amino acids and their derivatives. As the fundamental building blocks of proteins, amino acids play critical roles in various biological processes, including metabolism, signal transduction, and the pathogenesis of diseases. Amino acid mass spectrometry enables accurate profiling of amino acid composition and concentration changes in trace amounts of biological samples, thereby uncovering disease-associated metabolic dysregulation, biomarker alterations, and drug response mechanisms. This provides robust data support for biomarker-based drug development. Compared to traditional analytical approaches, amino acid mass spectrometry offers superior performance in terms of detection throughput, quantitative precision, and resistance to interference. It has been widely adopted in diverse fields such as clinical metabolic disorder screening, nutritional assessment, tumor biomarker discovery, and novel drug development. With the continuous advancement of precision medicine and systems biology, amino acid mass spectrometry has emerged as a core technology in biomarker drug development, supporting the entire continuum from mechanistic studies to clinical translation. Despite its notable advantages, amino acid mass spectrometry faces a range of technical and operational challenges in practical applications. On one hand, the substantial variability among amino acids in terms of polarity, hydrophobicity, and molecular mass complicates the development of effective chromatographic separation and mass spectrometric detection methods. On the other hand, endogenous background compounds can interfere with the detection of low-abundance analytes, particularly in complex matrices such as tissue homogenates. Moreover, sample pretreatment significantly affects the stability of analytical results, including factors such as derivatization efficiency, accuracy of deproteinization, and control of losses during concentration steps.

       

      From a technical standpoint, amino acid mass spectrometry predominantly relies on liquid chromatography–mass spectrometry (LC-MS) or gas chromatography–mass spectrometry (GC-MS) platforms. In recent years, the development of tandem mass spectrometry (LC-MS/MS) has greatly enhanced sensitivity, resolution, and quantification accuracy. These platforms typically employ derivatization during sample preparation to improve ionization efficiency and signal response of amino acids. Subsequent chromatographic separation ensures effective resolution, followed by mass spectrometric analysis of molecular mass and fragmentation patterns. Compared to conventional amino acid analysis techniques—such as ultraviolet detection or ion exchange chromatography—amino acid mass spectrometry offers significant advantages in analytical speed, sample efficiency, and throughput, making it particularly suitable for biomarker drug development in large-cohort and high-dimensional data settings.

       

      A typical experimental workflow in amino acid mass spectrometry involves six steps: sample collection, pretreatment, derivatization, chromatographic separation, mass spectrometric detection, and data modeling. During pretreatment, amino acids are derivatized using chemical reagents such as OPA, AQC, or FMOC to enhance ionization efficiency and detection sensitivity. Subsequently, liquid chromatography is used to finely tune gradient conditions for rapid and effective separation of multiple amino acids. The mass spectrometer enables precise quantification by targeting specific precursor and product ion transitions. In the downstream data analysis, biologically meaningful differential amino acids are identified through comparison with metabolic pathway databases, statistical modeling, and multivariate analysis, offering molecular insights critical for biomarker-driven drug discovery.

       

      MtoZ Biolabs specializes in delivering high-quality amino acid analysis services. Leveraging advanced experimental platforms and standardized analytical workflows, we assist clients in accelerating translational efficiency and advancing research outcomes toward clinical applications.

       

      MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider. 

      Related Services

    Submit Inquiry
    Name *
    Email Address *
    Phone Number
    Inquiry Project
    Project Description *

     

    How to order?


    /assets/images/icon/icon-message.png

    Submit Inquiry

    /assets/images/icon/icon-return.png